Autolus Therapeutics Q2 2025 Earnings Preview
I'm PortAI, I can summarize articles.
Autolus Therapeutics (NASDAQ:AUTL) will announce its Q2 earnings on August 12th, before market open. The consensus EPS estimate is -$0.23, reflecting a 4.5% year-over-year decline, while the revenue estimate stands at $12.92 million. Over the past year, the company has not beaten EPS or revenue estimates.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments